Siegall Clay B

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

-7.9%

median move per position

+9.7%

S&P 500 median, same spans

0 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$1.25M bought

All filings on record

Every Form 4 transaction we track for this filer

All6Buys3Sells0

Stock	Transaction	Date	~6mo vs S&P
STTKShattuck Labs, Inc.	Grant $138.9K · 128,054 sh	2026-05-22	—
IMNMImmunome Inc.	Buy $100.0K · 4,729 sh	2025-12-30	—
IMNMImmunome Inc.	Gift — · 200,000 sh	2025-12-19	—
IMNMImmunome Inc.	Buy $149.1K · 7,278 sh	2025-12-19	—
IMNMImmunome Inc.	Buy $1000.0K · 46,511 sh	2025-12-18	—
STTKShattuck Labs, Inc.	Grant $111.1K · 128,054 sh	2025-08-25	—

STTKGrant

2026-05-22 · Shattuck Labs, Inc.

$138.9K

—

IMNMBuy

2025-12-30 · Immunome Inc.

$100.0K

—

IMNMGift

2025-12-19 · Immunome Inc.

200,000

—

IMNMBuy

2025-12-19 · Immunome Inc.

$149.1K

—

IMNMBuy

2025-12-18 · Immunome Inc.

$1000.0K

—

STTKGrant

2025-08-25 · Shattuck Labs, Inc.

$111.1K

—

6 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

BI

Barchas Isaac

IMNM · last 2026-08-12

SA

Shukla Abhinav A.

STTK · last 2026-07-06

LR

Lechleider Robert

IMNM · last 2026-07-02

PA

Pandite Arundathy N.

STTK · last 2026-06-30

RM

Rosett Max

IMNM · last 2026-06-15

BJ

Bienaime Jean Jacques

IMNM · last 2026-06-05

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.